Featured
Prediabetes affects roughly 96 million U.S. adults, but GLP-1s are not the only answer. Here is what 2025-2026 evidence says about lifestyle, metformin, and when drugs fit.
TikTok pushes berberine as a natural GLP-1. Here is what 2025-2026 evidence says about the claim, the risks, and the reality.
A stubborn reading on medication panics patients. Here is what 2025-2026 evidence says about why pills lag and what actually lowers it.
The scale stops after early GLP-1 losses. Here is what 2025-2026 evidence says about plateaus, insulin, and what restarts progress.
Some women feel miserable starting hormone therapy. Here is what 2025-2026 evidence says about adjustment, red flags, and real relief.
Many people find magnesium triggers insomnia instead of calm. Here is what 2025-2026 evidence says about forms, timing, and what to do.
Hot homes threaten heat-sensitive meds. Here is what 2025-2026 evidence says about storage limits and protecting your prescriptions.
Beet juice and breathing hacks flood BP threads. Here is what 2025-2026 evidence says about what helps and what is hype.
Forgetting words mid-sentence terrifies women in perimenopause. Here is what 2025-2026 evidence says about the cause and real fixes.
Women with PCOS agonize over metformin vs GLP-1. Here is what 2025-2026 evidence says about which helps and the real tradeoffs.
Unexpected pharmacist interaction calls confuse patients. Here is what 2025-2026 evidence says about why they call and what to do.
The 'did I take it' panic leads to double doses. Here is what 2025-2026 evidence says about memory aids that actually work.
Cheap supplements with wild claims flood marketplaces. Here is what 2025-2026 evidence says about spotting fakes and staying safe.
Muscle pain drives many to abandon statins. Here is what 2025-2026 evidence says about real risk, safe switching, and protecting your heart.
Timing and food gut thyroid absorption. Here is what 2025-2026 evidence says about the right window and common mistakes.
Doctor visits are evolving rapidly due to AI and new care models. Discover how to navigate these shifts to ensure you get the best outcomes. 30% of US clinics now use AI.
Why is the search for a new oral cholesterol pill ongoing? While no new drug was approved in 2026, research shows current options can slash LDL-C by 25% ([CLEAR Outcomes](https://www.nejm.org/), 2023).
A drink can turn a safe drug risky. Here is what 2025-2026 evidence says about alcohol and medication interactions to avoid.
